Kevin J. McNamara
2020
In 2020, Kevin J. McNamara earned a total compensation of $12M as President and CEO at Chemed, a 19% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $54,566 |
|---|---|
| Non-Equity Incentive Plan | $3,065,892 |
| Option Awards | $4,021,813 |
| Salary | $1,305,992 |
| Stock Awards | $2,168,162 |
| Other | $1,341,998 |
| Total | $11,958,423 |
McNamara received $4M in option awards, accounting for 34% of the total pay in 2020.
McNamara also received $54.6K of change in pension value and nonqualified deferred compensation earnings, $3.1M in non-equity incentive plan, $1.3M in salary, $2.2M in stock awards and $1.3M in other compensation.
Rankings
In 2020, Kevin J. McNamara's compensation ranked 617th out of 13,090 executives tracked by ExecPay. In other words, McNamara earned more than 95.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 617 out of 13,090 | 95th |
Division Services | 187 out of 2,338 | 92nd |
Major group Health Services | 17 out of 252 | 93rd |
Industry group Home Health Care Services | 2 out of 35 | 94th |
Industry Home Health Care Services | 2 out of 35 | 94th |
Source: SEC filing on April 9, 2021.
McNamara's colleagues
We found four more compensation records of executives who worked with Kevin J. McNamara at Chemed in 2020.